NCT06990269Phase 2Recruiting

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Study sponsor: ADARx Pharmaceuticals, Inc. · ADRX

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2030-02-28Estimated
Enrollment · participants240Estimated
Source updated2026-11-13Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: 30 Sep 2027. After: 28 Feb 2030.

Check registry source

· 2 fields changed

Primary completion date changed

Before: Sep 2027. After: 30 Sep 2027.

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source